Showing results (161-170 of 1,036) with videos related to
Sort By:
Pageof 104
Neuroscience Letters|May 1, 1985
Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neuronesE Kelly, P Jenner, C D MarsdenJournal of Neural Transmission. Supplementum|January 1, 1988
Receptor changes during chronic dopaminergic stimulationP Jenner, S Boyce, C D MarsdenClinical Neuropharmacology|April 1, 1997
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesiasF Stocchi, G Nordera, C D MarsdenNeuroscience Letters|October 24, 1994
GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatmentJ Jolkkonen, P Jenner, C D MarsdenThe Journal of Pharmacy and Pharmacology|October 1, 1982
Are dopamine receptors present on human lymphocytes?S Fleminger, P Jenner, C D MarsdenThe Journal of Pharmacy and Pharmacology|August 1, 1993
Chronic administration does not alter the pharmacokinetic profile of L-dopa in the ratS Rose, P Jenner, C D MarsdenNeuroscience|May 1, 1985
Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidusD Dewar, P Jenner, C D MarsdenNeuroscience|January 1, 1991
The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic graftsS Blunt, P Jenner, C D MarsdenBiofeedback and Self-Regulation|December 1, 1991
EMG biofeedback treatment of torticollis: a controlled outcome studyM Jahanshahi, G Sartory, C D MarsdenAdvances in Neurology|January 1, 1986
5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor actionG Luscombe, P Jenner, C D MarsdenPageof 104